Recent Press Releases

Vaxart Begins Preclinical Testing of an Oral Zika Virus Vaccine

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection,...

Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax™ Platform

Company Joins Global Race to Find Vaccine; Previous Data Support Potential of Immunovaccine's DepoVax™ Platform Against Other Major Health Threats, Including RSV, Anthrax and Ebola Virus...

GeoVax to Collaborate With USAMRIID on Testing of GeoVax's Hemorrhagic Fever Vaccine

GeoVax Developing a Tetravalent Vaccine to Protect Against Multiple Viruses, Including Ebola, Marburg and Lassa Fever ATLANTA, GA--(Marketwired - Feb 29, 2016) - GeoVax Labs, Inc. (OTCQB: GOVX), a...

Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses in Preclinical Study

Biotech begins clinical manufacturing; expects to test Zika vaccine in humans in 2016 PLYMOUTH MEETING, Pa., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced...

Protein Sciences and UNIGEN Reach Agreement to Source Flublok® Influenza Vaccine from Japan

MERIDEN, Conn. and PEARL RIVER, N.Y., Feb. 12, 2016 /PRNewswire/ -- Protein Sciences Corporation (Meriden, CT and Pearl River, NY) and UMN Pharma Inc. (Akita, Akita prefecture, Japan) announced today...

Regeneron Joins Human Vaccines Project to Improve Global Disease Prevention and Treatment

Tarrytown, New York (February 10, 2016) - Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the Human Vaccines Project, a public-private partnership to help discover...

First-in-man trial of MERS vaccine begins

The Walter Reed Army Institute of Research (WRAIR) began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune response of a vaccine candidate to prevent Middle East...

Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses in Preclinical Study

Biotech begins clinical manufacturing; expects to test Zika vaccine in humans in 2016 PLYMOUTH MEETING, Pa., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced...

New study highlights effectiveness of a herpesvirus CMV-based vaccine against Ebola

As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a...

Experimental vaccine shows effectiveness in Ebola vaccine trial

An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa -- and the...

VALNEVA Signs New R&D Collaboration with GlaxoSmithKline for the EB66(r) Cell Line

Valneva to supply process development services for EB66®-based Influenza vaccines Advanced Development program sponsored by the US Department of Health and Human Services Valneva to receive...

VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability

CAMBRIDGE, Mass., Feb. 09, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) ("VBI") has entered into a research collaboration with GlaxoSmithKline Biologicals SA ("GSK")...

GeoVax Labs Inc. (GOVX.OB) To Develop Vaccine Against Zika Virus

ATLANTA, GA--(Marketwired - Feb 3, 2016) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it has begun a program to develop a vaccine for the...

Affinivax Secures Additional Funding to Advance its Novel Pneumococcal Vaccine towards Clinical Trials

Company achieves key milestones and additional $2.5 million from the Gates Foundation Cambridge, Mass., Feb. 5, 2016 – Affinivax Inc., a biotechnology company dedicated to developing novel...

Mymetics Announces Discontinuation of the RSV Collaborative Project

January 28, 2016: 10:00 PM ET Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases,...

Most vaccine-related posts on Pinterest are anti-vaccine, reveals research

Amsterdam, February 1, 2016 - 75% of the vaccine-related posts on Pinterest are negative towards vaccination, according to research published in Vaccine. The authors of the study, from Virginia...

GSK announces US regulatory submission seeking expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 mos+

GSK today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration for FLULAVAL® QUADRIVALENT (Influenza Vaccine). This vaccine is...

Chickenpox, shingles vaccine may cause corneal inflammation in some patients

COLUMBIA, Mo. (Jan. 20, 2016) -- In use for more than 20 years, the varicella zoster virus vaccine for chickenpox and shingles is considered an essential medicine by the World Health Organization...

VALNEVA Announces Successful Establishment of New Global Marketing and Distribution Network

IXIARO® marketing and distribution handover largely completed - excellent IXIARO® sales performance in 2015 and successful transition Valneva sales and marketing organizations established in...

Stellar Biotechnologies and Neovacs Propose to Form Joint Venture to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM)

PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - Jan 20, 2016) - Stellar Biotechnologies, Inc. ("Stellar") (NASDAQ: SBOT) (TSX VENTURE: KLH) and Neovacs S.A....